The prevention and regression of atherosclerotic plaques: emerging treatments
- PMID: 23049260
- PMCID: PMC3459726
- DOI: 10.2147/VHRM.S27764
The prevention and regression of atherosclerotic plaques: emerging treatments
Abstract
Occlusive vascular diseases, such as sudden coronary syndromes, stroke, and peripheral arterial disease, are a huge burden on the health care systems of developed and developing countries. Tremendous advances have been made over the last few decades in the diagnosis and treatment of atherosclerotic diseases. Intravascular ultrasound has been able to provide detailed information of plaque anatomy and has been used in several studies to assess outcomes. The presence of atherosclerosis disrupts the normal protective mechanism provided by the endothelium and this mechanism has been implicated in the pathophysiology of coronary artery disease and stroke. Efforts are being put into the prevention of atherosclerosis, which has been shown to begin in childhood. This paper reviews the pathophysiology of atherosclerosis and discusses the current options available for the prevention and reversal of plaque formation.
Keywords: atherosclerotic disease; cardiovascular; coronary artery disease; endothelium; plaque; reversal; stroke.
Similar articles
-
Anti-atherosclerosis and cardio-protective effects of the Angong Niuhuang Pill on a high fat and vitamin D3 induced rodent model of atherosclerosis.J Ethnopharmacol. 2017 Jan 4;195:118-126. doi: 10.1016/j.jep.2016.11.015. Epub 2016 Nov 20. J Ethnopharmacol. 2017. PMID: 27880884
-
An emerging paradigm in atherosclerosis: focus on subclinical disease.Postgrad Med. 2009 Mar;121(2):49-59. doi: 10.3810/pgm.2009.03.1976. Postgrad Med. 2009. PMID: 19332962 Review.
-
The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials.J Atheroscler Thromb. 2019 Jul 1;26(7):592-600. doi: 10.5551/jat.48603. Epub 2019 May 21. J Atheroscler Thromb. 2019. PMID: 31118346 Free PMC article. Review.
-
Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques: 3-year prevention with the supplementation with Pycnogenol®+Centellicum®.Minerva Cardioangiol. 2020 Feb;68(1):15-21. doi: 10.23736/S0026-4725.19.05051-5. Epub 2019 Oct 11. Minerva Cardioangiol. 2020. PMID: 31625707
-
Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?Clin Interv Aging. 2015 Jul 7;10:1111-9. doi: 10.2147/CIA.S85216. eCollection 2015. Clin Interv Aging. 2015. PMID: 26185430 Free PMC article.
Cited by
-
Association between LDL-C, Non HDL-C, and Apolipoprotein B Levels with Coronary Plaque Regression.Arq Bras Cardiol. 2015 Jul;105(1):11-9. doi: 10.5935/abc.20150050. Epub 2015 May 19. Arq Bras Cardiol. 2015. PMID: 26016784 Free PMC article. Review.
-
Recombinant Destabilase from Hirudo medicinalis Is Able to Dissolve Human Blood Clots In Vitro.Curr Issues Mol Biol. 2021 Nov 20;43(3):2068-2081. doi: 10.3390/cimb43030143. Curr Issues Mol Biol. 2021. PMID: 34889897 Free PMC article.
-
ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis.Arterioscler Thromb Vasc Biol. 2017 May;37(5):764-777. doi: 10.1161/ATVBAHA.117.308611. Epub 2017 Mar 30. Arterioscler Thromb Vasc Biol. 2017. PMID: 28360089 Free PMC article. Review.
-
Cysteamine Decreases Low-Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low-Density Lipoprotein Receptor-Deficient Mice.J Am Heart Assoc. 2021 Sep 21;10(18):e017524. doi: 10.1161/JAHA.120.017524. Epub 2021 Sep 8. J Am Heart Assoc. 2021. PMID: 34493066 Free PMC article.
-
ShenLian Extract Enhances TGF-β Functions in the Macrophage-SMC Unit and Stabilizes Atherosclerotic Plaques.Front Pharmacol. 2021 May 28;12:669730. doi: 10.3389/fphar.2021.669730. eCollection 2021. Front Pharmacol. 2021. PMID: 34122091 Free PMC article.
References
-
- Roger VL, Go AL, Lloyd-Jones DM, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Executive summary: heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation. 2012;125:188–197. - PubMed
-
- Heidenreich PA, Trogdon JG, Khavjou OA, et al. American Heart Association Advocacy Coordinating Committee. Stroke Council. Council on Cardiovascular Radiology and Intervention. Council on Clinical Cardiology. Council on Epidemiology and Prevention. Council on Arteriosclerosis. Thrombosis and Vascular Biology. Council on Cardiopulmonary. Critical Care. Perioperative and Resuscitation. Council on Cardiovascular Nursing. Council on the Kidney in Cardiovascular Disease. Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933–944. - PubMed
-
- Mallika V, Goswami B, Rajappa M. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology. 2007;58(5):513–522. - PubMed
-
- Fleming RM. The effect of high-, moderate-, and low-fat diets on weight loss and cardiovascular disease risk factors. Prev Cardiol. 2002;5(3):10–118. - PubMed
-
- Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115(10):1285–1295. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical